Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
31,030,594
-
Shares change
-
+6,667,488
-
Total reported value, excl. options
-
$970,020,757
-
Value change
-
+$215,509,581
-
Number of buys
-
71
-
Number of sells
-
-12
-
Price
-
$31.26
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2018
88 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2018.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,030,594 shares
of 66,399,673 outstanding shares and own 46.73% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4,912,306 shares), TRV GP, LLC (3,981,437 shares), MPM ASSET MANAGEMENT LLC (3,074,893 shares), BAKER BROS. ADVISORS LP (2,708,200 shares), JANUS HENDERSON GROUP PLC (2,291,785 shares), ORBIMED ADVISORS LLC (2,065,000 shares), FMR LLC (1,825,634 shares), RA CAPITAL MANAGEMENT, LLC (1,541,743 shares), VANGUARD GROUP INC (933,009 shares), and PERCEPTIVE ADVISORS LLC (800,686 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.